Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AVTR logo AVTR
Upturn stock ratingUpturn stock rating
AVTR logo

Avantor Inc (AVTR)

Upturn stock ratingUpturn stock rating
$13.46
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: AVTR (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

21 Analysts rated it

Highly popular stock, broad analyst coverage, trusted insights, strong investor interest.

1 Year Target Price $17.15

1 Year Target Price $17.15

Analysts Price Target For last 52 week
$17.15Target price
Low$11.82
Current$13.46
high$28

Analysis of Past Performance

Type Stock
Historic Profit -6.79%
Avg. Invested days 34
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 9.22B USD
Price to earnings Ratio 13.01
1Y Target Price 17.15
Price to earnings Ratio 13.01
1Y Target Price 17.15
Volume (30-day avg) 21
Beta 1.05
52 Weeks Range 11.82 - 28.00
Updated Date 06/30/2025
52 Weeks Range 11.82 - 28.00
Updated Date 06/30/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.04

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 10.7%
Operating Margin (TTM) 8.21%

Management Effectiveness

Return on Assets (TTM) 3.53%
Return on Equity (TTM) 12.52%

Valuation

Trailing PE 13.01
Forward PE 13.14
Enterprise Value 13010743340
Price to Sales(TTM) 1.38
Enterprise Value 13010743340
Price to Sales(TTM) 1.38
Enterprise Value to Revenue 1.95
Enterprise Value to EBITDA 8.9
Shares Outstanding 681430016
Shares Floating 663855592
Shares Outstanding 681430016
Shares Floating 663855592
Percent Insiders 1.35
Percent Institutions 103.15

Analyst Ratings

Rating 5
Target Price 17.15
Buy 4
Strong Buy 6
Buy 4
Strong Buy 6
Hold 11
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Avantor Inc

stock logo

Company Overview

overview logo History and Background

Avantor, Inc. was founded in 1904 as J.T. Baker Chemical Company. It evolved through various acquisitions and mergers, becoming a leading provider of products and services to the life sciences and advanced technologies industries.

business area logo Core Business Areas

  • Materials and Consumables: Offers a broad range of high-purity chemicals, reagents, labware, filtration products, single-use solutions, and other consumables for research, development, and production.
  • Services and Equipment: Provides services such as lab support, equipment maintenance and repair, instrument calibration, and custom manufacturing solutions. It also distributes analytical instruments and other laboratory equipment.

leadership logo Leadership and Structure

Avantor is led by a CEO and a senior management team overseeing its global operations. The organizational structure includes business units focused on specific customer segments and product categories.

Top Products and Market Share

overview logo Key Offerings

  • High-Purity Chemicals and Reagents: Essential for research, development, and manufacturing processes across various industries. Market share fluctuates but is estimated to be around 15-20% in specialized segments. Competitors include Merck KGaA and Thermo Fisher Scientific. Revenue for this segment is significant, accounting for a large portion of Avantoru2019s materials and consumables segment. Users include researchers, scientists, and manufacturers.
  • Single-Use Solutions: Used in biopharmaceutical manufacturing to eliminate the need for cleaning and sterilization. This market is growing rapidly. Competitors include Sartorius Stedim Biotech and Danaher Corporation (Cytiva). Market share estimates vary based on specific product types. Revenue for this sector is a significant area of growth for Avantor. Users are pharmaceutical companies.

Market Dynamics

industry overview logo Industry Overview

The life sciences and advanced technologies industries are driven by research, development, and manufacturing activities. Key trends include increasing demand for biopharmaceuticals, personalized medicine, and advanced materials.

Positioning

Avantor is positioned as a key supplier of high-quality materials, consumables, and services to these industries. Its competitive advantages include a broad product portfolio, global reach, and strong customer relationships.

Total Addressable Market (TAM)

The total addressable market for Avantor's products and services is estimated to be in the hundreds of billions of dollars globally. Avantor is positioned to capture a portion of this market through its diverse offerings and geographic reach.

Upturn SWOT Analysis

Strengths

  • Broad product portfolio
  • Global reach and distribution network
  • Strong customer relationships
  • Focus on high-quality products and services
  • Established brand reputation

Weaknesses

  • Exposure to economic cycles
  • Dependence on key suppliers
  • Integration risks from acquisitions
  • Complexity of managing a large, diverse organization

Opportunities

  • Growing demand for biopharmaceuticals
  • Expanding into emerging markets
  • Developing new and innovative products
  • Acquiring complementary businesses
  • Offering value added services

Threats

  • Increased competition
  • Pricing pressures
  • Regulatory changes
  • Disruptions in supply chain
  • Economic downturns

Competitors and Market Share

competitor logo Key Competitors

  • TMO
  • DHR
  • MRK

Competitive Landscape

Avantor competes with larger players in the life sciences industry. It differentiates itself through its focus on high-purity materials, consumables, and value added services.

Major Acquisitions

Masterflex Bioreactors

  • Year: 2021
  • Acquisition Price (USD millions): 2100
  • Strategic Rationale: To expand Avantoru2019s single-use bioprocessing portfolio.

Growth Trajectory and Initiatives

Historical Growth: Avantor has experienced growth through acquisitions and organic expansion. Data should be retrieved from a financial data provider.

Future Projections: Analysts project continued growth for Avantor, driven by demand in the life sciences and advanced technologies industries. Data should be retrieved from a financial data provider.

Recent Initiatives: Recent initiatives include acquisitions to expand its product portfolio and investments in new technologies.

Summary

Avantor is a key supplier in the life sciences and advanced technologies industries, driven by its wide-ranging portfolio and global network. The lack of dividends may deter some investors. Strategic acquisitions have boosted growth, but integration is crucial. Threats from increased competition and economic shifts are something to monitor.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings, industry reports, analyst estimates

Disclaimers:

The information provided is for informational purposes only and should not be considered investment advice. Financial data should be independently verified.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Avantor Inc

Exchange NYSE
Headquaters Radnor, PA, United States
IPO Launch date 2019-05-17
President, CEO & Director Mr. Michael Stubblefield
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 13500
Full time employees 13500

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.